Gleason Group »

Cue Biopharma shares owned by Gleason Group

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Gleason Group from 13F filings

Historical chart of Gleason Group investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Gleason Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Gleason Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $11k 6.0k 1.89
2023-12-31 $16k 6.0k 2.64
2023-09-30 $14k 6.0k 2.30
2023-06-30 $22k 6.0k 3.65

More positions owned by Gleason Group

Vanguard S&p 500 Etf idx (VOO)
Vanguard Total Stock Market ETF (VTI)
Vanguard Extended Market ETF (VXF)
Vanguard Value ETF (VTV)
Vanguard Growth ETF (VUG)
Vanguard Star Fd Intl Stk Idxf (VXUS)
Schwab Strategic Tr us lrg cap etf (SCHX)
iShares S&P 1500 Index Fund (ITOT)
Schwab International Equity ETF (SCHF)
Schwab U S Large Cap Growth ETF (SCHG)
Ishares Core Intl Stock Etf core (IXUS)
Vanguard Emerging Markets ETF (VWO)
Sch Us Mid-cap Etf etf (SCHM)
Vanguard Mid-Cap ETF (VO)
Vanguard Small-Cap ETF (VB)

View all positions for Gleason Group

Top funds holding Cue Biopharma

Vanguard Group
BlackRock
Bleichroeder
Geode Capital Management
Robertson Stephens Wealth Management
Dimensional Fund Advisors
Northern Trust
Millennium Management
Monaco Asset Management SAM
Sigma Planning
Bank of America Corporation
GSA Capital Partners
Stifel Financial
Citadel Advisors
Morgan Stanley

View all funds holding Cue Biopharma